dm+d

111165009

Articles

Search Articles

Medicine Compliance Aid Stability

ImuranAspen

Aspen
Imuran
Tablets f/c 25mg, 50mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from light. Airtight container
25 October 2022

Lactation Safety Information

In transplantation

In transplantation
See summary
Moderate level of published evidence of use in breastfeeding
Small amounts of active metabolite, 6-mercaptopurine, in breast milk
If high dose used, monitor infant blood counts
24 September 2020

For rheumatoid arthritis

For rheumatoid arthritis
See summary
Moderate level of published evidence of use in breastfeeding
Small amounts of active metabolite, 6-mercaptopurine, in breast milk
If high dose used, monitor infant blood counts
24 September 2020

For eczema

For eczema
Topical eczema preparation / corticosteroid if appropriate
Unlicensed indication in the UK
Moderate level of published evidence of use in breastfeeding
Small amounts of active metabolite, 6-mercaptopurine, in breast milk
Monitor for signs of infection and immunosuppression, and, if high dose used, infant blood counts
24 September 2020

For inflammatory bowel disease

For inflammatory bowel disease
See summary
Moderate level of published evidence of use in breastfeeding
Small amounts of active metabolite, 6-mercaptopurine, in breast milk
If high dose used, monitor infant blood counts
24 September 2020